Herpes simplex virus type 2 and syphilis infections with HIV: An evolving synergy in transmission and prevention

Current Opinion in HIV and AIDS

Volumn 4, Issue 4, 2009, Pages 294-299

  Tobian, Aaron A R ^a   Quinn, Thomas C ^a,b,c  

^a JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES   (United States)

^c Rangos Building ^*  (United States)

Author keywords

Genital ulcer disease; Herpes simplex virus type 2; HIV; Male circumcision; Prevention trials; Syphilis; Treponema pallidum

Indexed keywords

ACICLOVIR; ANTIRETROVIRUS AGENT; CHEMOKINE RECEPTOR CCR5; PLACEBO; VALACICLOVIR; VIRUS RNA;

ALCOHOLISM; CD4+ T LYMPHOCYTE; CIRCUMCISION; CLINICAL EFFECTIVENESS; CLINICAL TRIAL; DISEASE ASSOCIATION; DISEASE COURSE; DRUG TREATMENT FAILURE; GENITAL ULCER; HERPES SIMPLEX; HERPES SIMPLEX VIRUS 2; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INCIDENCE; INFECTION CONTROL; INFECTION PREVENTION; INFECTION RISK; LYMPHOCYTE COUNT; MIXED INFECTION; NONHUMAN; PATHOPHYSIOLOGY; PRIORITY JOURNAL; REVIEW; SEROCONVERSION; SEXUAL INTERCOURSE; SEXUALLY TRANSMITTED DISEASE; SYPHILIS; TREATMENT DURATION; TREATMENT OUTCOME; VIRUS ENTRY; VIRUS INHIBITION; VIRUS LOAD; VIRUS SHEDDING; VIRUS TRANSMISSION; COMORBIDITY; DISEASE TRANSMISSION; FEMALE; GENITAL HERPES; MALE;

COMORBIDITY; FEMALE; HERPES GENITALIS; HIV INFECTIONS; HUMANS; MALE; SYPHILIS;

EID: 67651175991     PISSN: 1746630X     EISSN: 17466318     Source Type: Journal    
DOI: 10.1097/COH.0b013e32832c1881     Document Type: Review

References (57)

1. Whitley RJ, Roizman B. Herpes simplex virus infections. Lancet 2001; 357:1513-1518.
2. Corey L, Handsfield HH. Genital herpes and public health: addressing a global problem. JAMA 2000; 283:791-794. (Pubitemid 30084620)
3. Corey L, Wald A, Celum CL, Quinn TC. The effects of herpes simplex virus-2 on HIV-1 acquisition and transmission: a review of two overlapping epidemics. J Acquir Immune Defic Syndr 2004; 35:435-445. (Pubitemid 38420652)
4. Fenton KA, Breban R, Vardavas R, et al. Infectious syphilis in high-income settings in the 21st century. Lancet Infect Dis 2008; 8:244-253.
5. Gupta R, Warren T, Wald A. Genital herpes. Lancet 2007; 370:2127-2137.
6. Malkin JE. Epidemiology of genital herpes simplex virus infection in developed countries. Herpes 2004; 11 (Suppl 1):2A-23A.
7. Zhang X, Wang C, Hengwei W, et al. Risk factors of HIV infection and prevalence of co-infections among men who have sex with men in Beijing, China. AIDS 2007; 21 (Suppl 8):S53-S57.
8. Patterson TL, Semple SJ, Staines H, et al. Prevalence and correlates of HIV infection among female sex workers in 2 Mexico-US border cities. J Infect Dis 2008; 197:728-732.
9. Chen XS, Yin YP, Tucker JD, et al. Detection of acute and established HIV infections in sexually transmitted disease clinics in Guangxi, China: implications for screening and prevention of HIV infection. J Infect Dis 2007; 196:1654-1661.
10. Zetola NM, Klausner JD. Syphilis and HIV infection: an update. Clin Infect Dis 2007; 44:1222-1228.
11. Stamm WE, Handsfield HH, Rompalo AM, et al. The association between genital ulcer disease and acquisition of HIV infection in homosexual men. JAMA 1988; 260:1429-1433.
12. Sheffield JS, Wendel GD Jr, McIntire DD, Norgard MV. Effect of genital ulcer disease on HIV-1 coreceptor expression in the female genital tract. J Infect Dis 2007; 196:1509-1516. This is the first study to demonstrate that CCR5-expressing cells are in higher numbers within genital ulcers and syphilitic tissue.
13. Ghanem KG, Moore RD, Rompalo AM, et al. Antiretroviral therapy is associated with reduced serologic failure rates for syphilis among HIV-infected patients. Clin Infect Dis 2008; 47:258-265.
14. Lama JR, Lucchetti A, Suarez L, et al. Association of herpes simplex virus type 2 infection and syphilis with human immunodeficiency virus infection among men who have sex with men in Peru. J Infect Dis 2006; 194:1459-1466. (Pubitemid 44706516)
15. Tassiopoulos KK, Seage G 3rd, Sam N, et al. Predictors of herpes simplex virus type 2 prevalence and incidence among bar and hotel workers in Moshi, Tanzania. J Infect Dis 2007; 195:493-501. This study evaluates prevalent and incident HSV-2 risk factors among high-risk individuals.
16. Tobian AA, Charvat B, Ssempijja V, et al. Factors associated with the prevalence and incidence of herpes simplex virus type 2 infections among men in Rakai, Uganda. J Infect Dis 2009; 99:945-949. This is the first study to evaluate incident HSV-2 risk factors in the general population in Africa.
17. Gray RH, Wawer MJ, Brookmeyer R, et al. Probability of HIV-1 transmission per coital act in monogamous, heterosexual, HIV-1-discordant couples in Rakai, Uganda. Lancet 2001; 357:1149-1153. (Pubitemid 32378686)
18. Kapiga SH, Sam NE, Bang H, et al. The role of herpes simplex virus type 2 and other genital infections in the acquisition of HIV-1 among high-risk women in northern Tanzania. J Infect Dis 2007; 195:1260-1269. (Pubitemid 46649610)
19. Schacker T, Ryncarz AJ, Goddard J, et al. Frequent recovery of HIV-1 from genital herpes simplex virus lesions in HIV-1-infected men. JAMA 1998; 280:61-66. (Pubitemid 28414998)
20. Rebbapragada A, Wachihi C, Pettengell C, et al. Negative mucosal synergy between herpes simplex type 2 and HIV in the female genital tract. AIDS 2007; 21:589-598. (Pubitemid 46303652)
21. Corey L. Synergistic copathogens: HIV-1 and HSV-2. N Engl J Med 2007; 356:854-856.
22. Holmberg SD, Stewart JA, Gerber AR, et al. Prior herpes simplex virus type 2 infection as a risk factor for HIV infection. JAMA 1988; 259:1048-1050. (Pubitemid 18046855)
23. + T cells.
24. Sheth PM, Sunderji S, Shin LY, et al. Coinfection with herpes simplex virus type 2 is associated with reduced HIV-specific T cell responses and systemic immune activation. J Infect Dis 2008; 197:1394-1401. (Pubitemid 351706463)
25. Van de Perre P, Segondy M, Foulongne V, et al. Herpes simplex virus and HIV-1: deciphering viral synergy. Lancet Infect Dis 2008; 8:490-497. (Pubitemid 352005823)
26. Powers KA, Poole C, Pettifor AE, Cohen MS. Rethinking the heterosexual infectivity of HIV-1: a systematic review and meta-analysis. Lancet Infect Dis 2008; 8:553-563. A meta-analysis that estimates HIV heterosexual transmission cofactors.
27. Abu-Raddad LJ, Magaret AS, Celum C, et al. Genital herpes has played a more important role than any other sexually transmitted infection in driving HIV prevalence in Africa. PLoS ONE 2008; 3:e2230. A model of HSV-2 and HIV interactions that suggests HSV-2 has a prominent role in HIV spread.
28. Serwadda D, Gray RH, Sewankambo NK, et al. Human immunodeficiency virus acquisition associated with genital ulcer disease and herpes simplex virus type 2 infection: a nested case-control study in Rakai, Uganda. J Infect Dis 2003; 188:1492-1497. (Pubitemid 37523934)
29. Mbopi-Keou FX, Gresenguet G, Mayaud P, et al. Interactions between herpes simplex virus type 2 and human immunodeficiency virus type 1 infection in African women: opportunities for intervention. J Infect Dis 2000; 182:1090-1096. (Pubitemid 30736807)
30. McClelland RS, Wang CC, Overbaugh J, et al. Association between cervical shedding of herpes simplex virus and HIV-1. AIDS 2002; 16:2425-2430. (Pubitemid 35471690)
31. Baeten JM, McClelland RS, Corey L, et al. Vitamin A supplementation and genital shedding of herpes simplex virus among HIV-1-infected women: a randomized clinical trial. J Infect Dis 2004; 189:1466-1471. (Pubitemid 38543596)
32. Cowan FF, Pascoe SJ, Barlow KL, et al. Association of genital shedding of herpes simplex virus type 2 and HIV-1 among sex workers in rural Zimbabwe. AIDS 2006; 20:261-267.
33. Cachay ER, Frost SD, Richman DD, et al. Herpes simplex virus type 2 infection does not influence viral dynamics during early HIV-1 infection. J Infect Dis 2007; 195:1270-1277.
34. Nagot N, Ouedraogo A, Konate I, et al. Roles of clinical and subclinical reactivated herpes simplex virus type 2 infection and human immunodefi- ciency virus type 1 (HIV-1)-induced immunosuppression on genital and plasma HIV-1 levels. J Infect Dis 2008; 198:241-249. Using longitudinal samples, this study extended observations that genital and plasma viral loads are higher among individuals with GUD or HSV-2 DNA shedding. (Pubitemid 352035760)
35. Nagot N, Ouedraogo A, Foulongne V, et al. Reduction of HIV-1 RNA levels with therapy to suppress herpes simplex virus. N Engl J Med 2007; 356:790-799. This is the first study in women to demonstrate that valacyclovir decreases plasma and genital viral loads. (Pubitemid 46294611)
36. Zuckerman RA, Lucchetti A, Whittington WL, et al. Herpes simplex virus (HSV) suppression with valacyclovir reduces rectal and blood plasma HIV-1 levels in HIV-1/HSV-2-seropositive men: a randomized, double-blind, placebo- controlled crossover trial. J Infect Dis 2007; 196:1500-1508. The first randomized control trial in MSM to show that valacyclovir decreases both plasma and rectal HIV viral loads.
37. Baeten JM, Strick LB, Lucchetti A, et al. Herpes simplex virus (HSV)- suppressive therapy decreases plasma and genital HIV-1 levels in HSV-2/ HIV-1 coinfected women: a randomized, placebo-controlled, cross-over trial. J Infect Dis 2008; 198:1804-1808. A randomized crossover trial in women to show that valacyclovir decreases both plasma and cervical HIV viral loads.
38. Watson-Jones D, Weiss HA, Rusizoka M, et al. Effect of herpes simplex suppression on incidence of HIV among women in Tanzania. N Engl J Med 2008; 358:1560-1571. The first randomized control trial of 821 women to demonstrate that acyclovir does not reduce HIV acquisition.
39. Celum C, Wald A, Hughes J, et al. Effect of aciclovir on HIV-1 acquisition in herpes simplex virus 2 seropositive women and men who have sex with men: a randomised, double-blind, placebo-controlled trial. Lancet 2008; 371:2109-2119. The definitive randomized clinical trial of 3277 women and MSMs that demonstrates acyclovir does not reduce HIV acquisition. (Pubitemid 351902179)
40. Freeman EE, Weiss HA, Glynn JR, et al. Herpes simplex virus 2 infection increases HIV acquisition in men and women: systematic review and metaanalysis of longitudinal studies. AIDS 2006; 20:73-83.
41. Gray RH, Kigozi G, Serwadda D, et al. Male circumcision for HIV prevention in men in Rakai, Uganda: a randomised trial. Lancet 2007; 369:657-666.
42. Bailey RC, Moses S, Parker CB, et al. Male circumcision for HIV prevention in young men in Kisumu, Kenya: a randomised controlled trial. Lancet 2007; 369:643-656.
43. Auvert B, Taljaard D, Lagarde E, et al. Randomized, controlled intervention trial of male circumcision for reduction of HIV infection risk: the ANRS 1265 Trial. PLoS Med 2005; 2:e298. (Pubitemid 41735779)
44. Auvert B, Buve A, Lagarde E, et al. Male circumcision and HIV infection in four cities in sub-Saharan Africa. AIDS 2001; 15 (Suppl 4):S31-S40. (Pubitemid 32913002)
45. Weiss HA, Buve A, Robinson NJ, et al. The epidemiology of HSV-2 infection and its association with HIV infection in four urban African populations. AIDS 2001; 15 (Suppl 4):S97-S108. (Pubitemid 32913009)
46. Xu F, Markowitz LE, Sternberg MR, Aral SO. Prevalence of circumcision and herpes simplex virus type 2 infection in men in the United States: the National Health and Nutrition Examination Survey (NHANES), 1999-2004. Sex Transm Dis 2007; 34:479-484.
47. Gottlieb SL, Douglas JM Jr, Foster M, et al. Incidence of herpes simplex virus type 2 infection in 5 sexually transmitted disease (STD) clinics and the effect of HIV/STD risk-reduction counseling. J Infect Dis 2004; 190:1059-1067. (Pubitemid 39186791)
48. Kapiga SH, Sam NE, Shao JF, et al. Herpes simplex virus type 2 infection among bar and hotel workers in northern Tanzania: prevalence and risk factors. Sex Transm Dis 2003; 30:187-192. (Pubitemid 36297635)
49. Lavreys L, Rakwar JP, Thompson ML, et al. Effect of circumcision on incidence of human immunodeficiency virus type 1 and other sexually transmitted diseases: a prospective cohort study of trucking company employees in Kenya. J Infect Dis 1999; 180:330-336. (Pubitemid 30256312)
50. Reynolds SJ, Shepherd ME, Risbud AR, et al. Male circumcision and risk of HIV-1 and other sexually transmitted infections in India. Lancet 2004; 363:1039-1040. (Pubitemid 38410778)
51. Gray R, Azire J, Serwadda D, et al. Male circumcision and the risk of sexually transmitted infections and HIV in Rakai, Uganda. AIDS 2004; 18:2428-2430. (Pubitemid 40065911)
52. Obasi A, Mosha F, Quigley M, et al. Antibody to herpes simplex virus type 2 as a marker of sexual risk behavior in rural Tanzania. J Infect Dis 1999; 179:16-24. (Pubitemid 29028333)
53. Bwayo J, Plummer F, Omari M, et al. Human immunodeficiency virus infection in long-distance truck drivers in east Africa. Arch Intern Med 1994; 154:1391-1396. (Pubitemid 24197683)
54. Cook LS, Koutsky LA, Holmes KK. Circumcision and sexually transmitted diseases. Am J Public Health 1994; 84:197-201.
55. Urassa M, Todd J, Boerma JT, et al. Male circumcision and susceptibility to HIV infection among men in Tanzania. AIDS 1997; 11:73-80. (Pubitemid 27023215)
56. Weiss HA, Thomas SL, Munabi SK, Hayes RJ. Male circumcision and risk of syphilis, chancroid, and genital herpes: a systematic review and metaanalysis. Sex Transm Infect 2006; 82:101-109; discussion 110.
57. Tobian AAR, Serwadda D, Quinn TC, et al. Male circumcision for the prevention of HSV-2 and HPV infections and syphilis. N Engl J Med 2009; 360:1298-1309. The first study of secondary endpoints of a randomized control trial to demonstrate that male circumcision decreases both HSV-2 and HPV infections, but has no influence on syphilis infection.